Stock data
Biogen Inc. (BIIB)
Biogen Inc. (BIIB) reported revenue of US$9.89B and net income of US$1.29B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$9.89B | — | — | US$1.29B | — |
| 2024 | US$9.68B | — | — | US$1.63B | — |
| 2023 | US$9.84B | — | — | US$1.16B | — |
| 2022 | US$10.17B | — | — | US$3.05B | — |
| 2021 | US$10.98B | — | US$2.84B | US$1.56B | — |
Quarterly results
Data as of 2026-03-31
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-03-31 | US$2.48B | US$319.50M | — |
| 2025-12-31 | US$2.28B | -US$48.90M | — |
| 2025-09-30 | US$2.53B | US$466.50M | — |
| 2025-06-30 | US$2.65B | US$634.80M | — |
| 2025-03-31 | US$2.43B | US$240.50M | — |
| 2024-12-31 | US$2.45B | US$266.70M | — |
| 2024-09-30 | US$2.47B | US$388.50M | — |
| 2024-06-30 | US$2.46B | US$583.60M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.